MASSACHUSETTS EYE AND EAR INFIRMARY
Patent Owner
Stats
- 134 US PATENTS IN FORCE
- 21 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 134 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,288 Total Citation Count
- Dec 30, 1986 Earliest Filing
- 81 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0064,375 AUDITORY STIMULUS FOR AUDITORY REHABILITATIONOct 16, 17Mar 08, 18[G09B, A61B, G06F, A61M]
2018/0043,034 GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENEMar 07, 16Feb 15, 18[A61K, C12N]
2017/0348,384 Treatment of Rhinosinusitis with P-glycoprotein InhibitorsAug 25, 17Dec 07, 17[A61K, A61L]
2017/0314,027 INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTIONAug 06, 15Nov 02, 17[A61K, C12N, C07K]
2017/0043,015 METHODS FOR CROSS-LINKING CORNEAL COLLAGEN WITH VERTEPORFIN FOR THE TREATMENT OF DISORDERS OF THE EYEFeb 26, 15Feb 16, 17[A61K, A61F, A61N]
2017/0020,909 METHODS OF TREATING GLAUCOMA USING AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORSMar 10, 15Jan 26, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9913854 Methods and compositions for reducing the proliferation of gram positive bacteriaMar 14, 13Mar 13, 18[A61K, A01N, C07D, C09B]
9914782 Methods for preserving the viability of retinal ganglion cells in patients with glaucoma by an anti-TNF receptor 2 (anti-TNFR2) antibodyJul 29, 15Mar 13, 18[A61K, C12N, G01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2018/0000,791 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITORAbandonedFeb 10, 17Jan 04, 18[A61K, C12N, A61N, C07K]
2016/0279,104 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITORAbandonedNov 09, 15Sep 29, 16[A61K, A61N]
2016/0271,224 METHODS OF REDUCING CORNEAL ENDOTHELIAL CELL LOSSAbandonedNov 20, 14Sep 22, 16[A61K, A61B]
2016/0144,024 Methods and Compositions for Preserving the Viability of Photoreceptor CellsAbandonedJul 29, 15May 26, 16[A61K]
2014/0357,570 COMPOSITIONS COMPRISING NECROSIS INHIBITORS, SUCH AS NECROSTATINS, ALONE OR IN COMBINATION, FOR PROMOTING AXON REGENERATION AND NERVE FUNCTION, THEREBY TREATING CNS DISORDERSAbandonedOct 22, 12Dec 04, 14[A61K]
2014/0178,407 Methods and Compositions for Treating Conditions of the EyeAbandonedJul 23, 13Jun 26, 14[A61K]
2014/0170,160 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITORAbandonedNov 01, 13Jun 19, 14[A61K, C12N, A61N, C07K]
2014/0163,451 Methods and Compositions for Treating Conditions of the EyeAbandonedAug 12, 13Jun 12, 14[A61K, A61N]
2014/0134,136 COMPOSITIONS AND METHODS FOR AUDITORY THERAPYAbandonedNov 04, 13May 15, 14[C12N, C07K]
2014/0024,598 METHODS AND COMPOSITIONS FOR PRESERVING RETINAL GANGLION CELLSAbandonedOct 21, 11Jan 23, 14[A61K]
2014/0004,510 METHODS AND COMPOSITIONS FOR PROGNOSING AND/OR DETECTING AGE-RELATED MACULAR DEGENERATIONAbandonedSep 23, 11Jan 02, 14[C12Q]
2013/0122,016 Methods and Compositions for Prognosing, Detecting, and Treating Age-Related Macular DegenerationAbandonedJul 09, 12May 16, 13[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.